Presented by: Muhammad M. Sidat
Presented at: Jornadas Nacionais de Saude
Pedicap Publications
Impacto da passagem oral à Amoxicilina ou Co-amoxiclav e da duração da terapêutica antibiótica na eficácia, segurança e selecção da resistência antibiótica na Pneumonia severa infantil adquirida na comunidade (PAC) – ensaio clínico PediCAP
Presented by: Muhammad M. Sidat, em nome da equipe do ensaio PediCAP
Presented at: Simpósio Pré-Evento, XIII Conferência Científica da UEM
Tolerability and Acceptability of Dispersible Oral Tablets of Amoxicillin and Co-Amoxiclav in African Children Hospitalized with Severe Pneumonia: Results from the PediCAP trial
Presented by: Sidat MM, on behalf of the PediCAP trial team
Presented at: INSPiRED 2025
Detection of respiratory pathogens in the nasopharynx of children hospitalised with severe pneumonia in sub-Saharan Africa
Presented by: P. Rodriguez-Ruiz, K. Loens, V. Musiime, M. Clements, S. Walker, J. Bielicki, M. Sharland, S. Malhotra-Kumar
Presented at: ESCMID Global 2025
The gastrointestinal resistome and microbiota of children hospitalised with severe pneumonia in sub-Saharan Africa in the PediCAP trial
Authors: P. Rodriguez-Ruiz, S. Hiel, V. Musiime, M. Clements, S. Walker, J. Bielicki, M. Sharland, S. Malhotra-Kumar
Presented at: ESCMID Global 2025
Early oral step-down to amoxicillin is safe and effective for children hospitalised with severe community-acquired pneumonia: the PediCAP trial
Presented by: Musiime V on behalf of the PediCAP trial team
Presented at: 20th UPA Annual Scientific Conference 2024
Impacto da passagem oral à Amoxicilina ou Co-amoxiclav e da duração da terapêutica antibiótica na eficácia, segurança e selecção da resistência antibiótica na Pneumonia severa infantil adquirida na comunidade (PAC) – ensaio clínico PediCAP
Authors: Issa F, Sidat M, Joaquim W, Maieca A, Massitela C, Adriano Q, Cassia U, Martins S, Chilundo J, Manjate N, Macanze E, Sigaúque A, Chilengue R, Bombe M, Florindo N, Nhacumba S, Buck WC, Sacarlal J, Musiime V, Sharland M, grupo do ensaio PediCAP
Presented at: Jornadas de AMOPE 2024
New amoxicillin-clavulanate dispersible tablets in children: a population pharmacokinetic analysis
Authors: Dyk vJ on behalf of the PediCAP trial team
Presented at: PAGE 2024
Economic impact of paediatric community acquired pneumonia in sub-Saharan Africa
Authors: Chitando M, Cleary S, Cunnama L
Presented at: ESCMID Global 2024
Early oral step-down to amoxicillin is safe and effective for children hospitalised with severe community-acquired pneumonia: the PediCAP trial
Authors: Musiime V on behalf of the PediCAP trial team
Presented at: ESCMID Global 2024